Chitwing(002855)

Search documents
捷荣技术(002855) - 关于全资子公司接受财务资助暨关联交易的公告
2025-05-20 11:48
证券代码:002855 证券简称:捷荣技术 公告编号:2025-024 东莞捷荣技术股份有限公司 关于全资子公司接受财务资助暨关联交易的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 一、本次关联交易基本情况 (一)本次关联交易概述 为了提高融资效率,满足日常生产经营的资金需求,东莞捷荣技术股份有限 公司(以下简称"公司")的全资子公司捷荣模具工业(香港)有限公司(以下 简称"香港捷荣")拟接受公司的控股股东捷荣科技集团有限公司(以下简称"捷 荣集团")不超过 1,500 万港元的财务资助,期限自本事项经公司董事会审议通 过之日起不超过 12 个月,利率不高于捷荣集团注册地中国香港市场的同期银行 贷款利率。香港捷荣根据实际情况可以在前述期限及额度内循环使用,可以提前 还款。 公司分别于 2024 年 8 月 22 日、2024 年 9 月 10 日召开第四届董事会第八次 会议审议和 2024 年第四次临时股东大会审议通过了《关于全资子公司接受财务 资助暨关联交易的议案》,同意公司的全资子公司捷荣模具工业(香港)有限公 司(以下简称"香港捷荣")接受公司的 ...
捷荣技术(002855) - 2025-022 关于公司全资子公司退还部分土地使用权暨投资进展的公告
2025-05-20 11:48
证券代码:002855 证券简称:捷荣技术 公告编号:2025-022 东莞捷荣技术股份有限公司 关于公司全资子公司退还部分土地使用权暨投资进展的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 一、投资情况概述 东莞捷荣技术股份有限公司(以下简称"公司"或"乙方")分别于 2017 年 4 月 11 日、2017 年 4 月 27 日、2017 年 9 月 26 日公告了关于公司与重庆市渝北区人 民政府签订《投资协议》的相关事项,具体内容详见公司在指定信息披露媒体披 露的《关于拟与重庆市渝北区人民政府签订<投资协议>的公告》及其进展公告 (公告编号:2017-012、2017-023、2017-049)。 2017 年 12 月 19 日,公司全资子公司重庆捷荣汇盈制造精密有限公司在重 庆取得国有建设用地使用权(重庆临空前沿科技城 N3-15/03、N3-16-1/02、N3- 17/04 号土地使用权),具体内容详见公司在指定信息披露媒体披露的《关于全 资子公司取得土地使用权的公告》(公告编号:2017-056)。 基于公司目前产业发展的规划调整,公司 ...
捷荣技术(002855) - 关于召开2025年第二次临时股东大会的通知
2025-05-20 11:46
证券代码:002855 证券简称:捷荣技术 公告编号:2025-023 东莞捷荣技术股份有限公司 关于召开 2025 年第二次临时股东大会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示: 1、股东大会召开时间:2025 年 6 月 11 日(星期三)下午 14:50 2、股东大会召开地点:广东省深圳市南山区科技园中区科技中三路 5 号国 人通信大厦 A 栋 10 楼公司会议室 2、网络投票时间:2025 年 6 月 11 日 通过深圳证券交易所交易系统进行网络投票的具体时间为 2025 年 6 月 11 日 上午 9:15 至 9:25,9:30 至 11:30,下午 13:00 至 15:00; 通过深圳证券交易所互联网投票系统投票的具体时间为 2025 年 6 月 11 日上 午 9:15 至下午 15:00 期间的任意时间。 3、会议方式:现场投票与网络投票相结合方式 东莞捷荣技术股份有限公司(以下简称"公司")第四届董事会第十五次会 议审议通过了《关于提议召开 2025 年第二次临时股东大会的议案》,决定于 2025 年 6 月 ...
捷荣技术(002855) - 第四届董事会第十五次会议决议公告
2025-05-20 11:45
证券代码:002855 证券简称:捷荣技术 公告编号:2025-021 东莞捷荣技术股份有限公司 第四届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 本议案尚需提交公司股东大会审议。 2、《关于全资子公司接受财务资助暨关联交易的议案》 为了提高融资效率,满足日常生产经营的资金需求,同意东莞捷荣技术股份 有限公司(以下简称"公司")的全资子公司捷荣模具工业(香港)有限公司(以 下简称"香港捷荣")接受公司的控股股东捷荣科技集团有限公司(以下简称"捷 荣集团")不超过 1,500 万港元的财务资助,期限自本事项经公司董事会审议通 过之日起不超过 12 个月,利率不高于捷荣集团注册地中国香港市场的同期银行 贷款利率。香港捷荣根据实际情况可以在前述期限及额度内循环使用,可以提前 还款。 一、董事会会议召开情况 东莞捷荣技术股份有限公司(以下简称"公司")第四届董事会第十五次会议 通知于 2025 年 5 月 19 日发出,会议于 2025 年 5 月 20 日在公司会议室以现场 结合通讯方式召开。会议由董事长张守智先生召集和主持,应参加董 ...
捷荣技术(002855) - 2024年年度股东大会法律意见书
2025-05-15 11:30
康达律师事务所 股东大会法律意见书 深圳市福田区中心四路一号嘉里建设广场 T1-19 层 19/F, Kerry Plaza Tower 1,1-1 Zhongxin4th Road, Futian District, Shenzhen 邮编/Zip Code:518048 电话/Tel:0755-88600388 电子邮箱/E-mail:kangda@kangdalawyers.com 北京 西安 深圳 海口 上海 广州 杭州 沈阳 南京 天津 菏泽 成都 苏州 呼和浩特 香港 武汉 郑州 长沙 厦门 重庆 合肥 宁波 济南 昆明 北京市康达(深圳)律师事务所 关于东莞捷荣技术股份有限公司 2024年度股东大会的 法律意见书 康达(深圳)股会字【2025】第 0012 号 致:东莞捷荣技术股份有限公司(下称"公司") 北京市康达(深圳)律师事务所(以下简称"本所")接受公司的委托,指派 本所律师参加公司 2024 年度股东大会(以下简称"本次会议")。 本所律师根据《中华人民共和国公司法》(以下简称"《公司法》")、《中华 人民共和国证券法》(以下简称"《证券法》")、《上市公司股东大会规则》(以下 简称" ...
捷荣技术(002855) - 2024年年度股东大会决议公告
2025-05-15 11:30
证券代码:002855 证券简称:捷荣技术 公告编号:2025-020 东莞捷荣技术股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 重要提示: 1、本次股东大会未出现否决提案的情形。 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 (一)会议召开的情况 1、会议召开时间: (1)现场会议召开时间为:2025 年 5 月 15 日(星期四)下午 14:50; (2)网络投票时间:通过深圳证券交易所交易系统进行网络投票的具体时 间为 2025 年 5 月 15 日上午 9:15 至 9:25,9:30 至 11:30,下午 13:00 至 15:00; 通过深圳证券交易所互联网投票系统投票的具体时间为 2025 年 5 月 15 日上 午 9:15 至下午 15:00 期间的任意时间。 2、现场会议召开地点:广东省深圳市南山区科技园中区科技中三路 5 号国 人通信大厦 A 栋 10 楼公司会议室。 3、召集人:公司董事会 本次股东大会的召开符合《公司法》《深圳证券交易所股票上市规则》和《 ...
惠伦晶体及实控人被证监会立案;捷荣技术一季度归母净亏损8680万元丨东莞金融市场周报
2 1 Shi Ji Jing Ji Bao Dao· 2025-04-28 07:06
南方财经全媒体记者程浩 东莞报道 本期看点:东莞一季度制造业贷款3762亿元,规模居全市行业贷款首位;东锦龙股份实控人股权被二次 拍卖;惠伦晶体及实控人因涉嫌信披违法违规被证监会立案;慕思股份增收不增利,年报季报业绩双下 滑;东莞控股一季度净利润同比减少45.58%;捷荣技术一季度归母净亏损8680万元;众生药业2024年 净亏损2.99亿元,同比由盈转亏。 1、金融要闻东莞一季度制造业贷款3762亿元,规模居全市行业贷款首位 近日,记者从人民银行东莞市分行获悉,截至3月末,东莞市本外币各项贷款余额1.98万亿元,比年初 增加523亿元。其中,小微企业贷款余额4223亿元,同比增长17.4%,普惠口径小微贷款余额4228亿 元,规模稳居广东省地级市首位;制造业贷款余额3762亿元,规模稳居全市行业贷款首位。 信贷资源持续流向重大战略、重点领域和薄弱环节。数据显示,截至3月末,东莞全市科技型中小企业 贷款余额136亿元,同比增长34.4%,专精特新"小巨人"企业贷款余额199亿元,同比增长32.1%;小微 企业贷款余额4223亿元,同比增长17.4%,普惠口径小微贷款余额4228亿元,规模稳居广东省地级市首 位 ...
4月24日晚间重要公告一览
Xi Niu Cai Jing· 2025-04-24 10:18
Group 1 - Shenjian Co., Ltd. reported a net profit of 33.65 million yuan for 2024, a year-on-year increase of 32.29%, with a proposed cash dividend of 0.5 yuan per 10 shares [1] - Jingce Electronics experienced a net loss of 97.60 million yuan in 2024, transitioning from profit to loss, despite a revenue increase of 5.59% to 2.565 billion yuan [1] - Jingwei Co., Ltd. reported a net profit of 35.54 million yuan for 2024, a decrease of 36.76%, with a proposed cash dividend of 1.00 yuan per 10 shares [1][2] Group 2 - Minsheng Health achieved a net profit of 91.83 million yuan in 2024, a year-on-year increase of 7.24%, with a proposed cash dividend of 1.00 yuan per 10 shares [2] - Zhongshe Co., Ltd. reported a net profit of 10.16 million yuan for 2024, a decline of 76.24%, with a proposed cash dividend of 0.2 yuan per 10 shares [3] - Keyuan Smart reported a net profit of 252 million yuan for 2024, a year-on-year increase of 56.64%, with a proposed cash dividend of 0.4 yuan per 10 shares [4] Group 3 - Beilu Pharmaceutical reported a net profit of 14.54 million yuan for Q1 2025, a year-on-year increase of 26.13%, with revenue of 283 million yuan [5] - Wangsu Technology achieved a net profit of 192 million yuan for Q1 2025, a year-on-year increase of 38.54%, with revenue of 1.235 billion yuan [6] - Keyuan Pharmaceutical reported a net profit of 23.08 million yuan for Q1 2025, a year-on-year increase of 7.25%, despite a revenue decline of 23.98% [7] Group 4 - Guangting Information reported a net profit of 24.03 million yuan for Q1 2025, turning from loss to profit, with revenue of 134 million yuan [9] - Zhaori Technology reported a net loss of 1.23 million yuan for Q1 2025, with revenue of 35.23 million yuan [11] - Huakai Yibai reported a net loss of 15.09 million yuan for Q1 2025, despite revenue growth of 35.08% to 2.292 billion yuan [13] Group 5 - Xinhongye reported a net profit of 34.43 million yuan for Q1 2025, a year-on-year increase of 20.43%, with revenue of 755 million yuan [15] - Huning Co., Ltd. reported a net profit of 3.61 million yuan for Q1 2025, a year-on-year decrease of 45.68%, with revenue of 64.51 million yuan [16] - Camel Co., Ltd. reported a net profit of 237 million yuan for Q1 2025, a year-on-year increase of 51.89%, with revenue of 4.136 billion yuan [17] Group 6 - Hengtong Co., Ltd. reported a net profit of 42.55 million yuan for Q1 2025, a year-on-year increase of 51.62%, with revenue of 313 million yuan [19] - Changqing Technology reported a net profit of 35.38 million yuan for Q1 2025, a year-on-year decrease of 23.80%, with revenue of 246 million yuan [21] - Libaba Co., Ltd. reported a net profit of 34.72 million yuan for Q1 2025, a year-on-year increase of 9.91%, with revenue of 419 million yuan [22] Group 7 - Shouxiangu reported a net profit of 58.37 million yuan for Q1 2025, a year-on-year decrease of 24.32%, with revenue of 171 million yuan [24] - Bojun Technology announced a stock issuance application accepted by the Shenzhen Stock Exchange [24] - Dayou Energy announced the full resumption of production at its Gengcun coal mine, with an annual production capacity of 3.6 million tons [25] Group 8 - Deyang Co., Ltd. successfully acquired land use rights for industrial land in Ningbo for 45.80 million yuan [27] - Tianyu Pharmaceutical's subsidiary received a drug registration certificate for an injectable product [29] - Xingwang Yuda signed a strategic cooperation agreement with the Jilin Province Bionic Robot Innovation Center [30] Group 9 - Lifang Pharmaceutical received approval for clinical trials of a new drug [32] - Zai Sheng Technology reported a net profit of 33.56 million yuan for Q1 2025, a year-on-year increase of 3.69%, with revenue of 324 million yuan [34] - Jinxin Technology reported a net profit of 319,920 yuan for Q1 2025, turning from loss to profit, with revenue of 563 million yuan [36] Group 10 - Huayin Electric reported a net profit of 75.67 million yuan for Q1 2025, a year-on-year increase of 894.61%, with revenue of 2.307 billion yuan [37] - Xinghua Co., Ltd. reported a net loss of 95.51 million yuan for Q1 2025, with revenue of 840 million yuan [38] - Heren Technology reported a net loss of 384,410 yuan for Q1 2025, with revenue of 78.40 million yuan [40] Group 11 - Fenda Technology reported a net profit of 40.45 million yuan for Q1 2025, a year-on-year increase of 84.07%, with revenue of 760 million yuan [41] - Tongda Co., Ltd. reported a net profit of 25.49 million yuan for 2024, a year-on-year decrease of 69.15%, with revenue of 6.201 billion yuan [43] - Zhonghe Holdings reported a net profit of 283 million yuan for 2024, a year-on-year decrease of 54.69%, with a proposed cash dividend of 0.3 yuan per 10 shares [44] Group 12 - Jiantou Energy reported a net profit of 531 million yuan for 2024, a year-on-year increase of 181.59%, with a proposed cash dividend of 1.3 yuan per 10 shares [44] - Guanghua Technology reported a net loss of 205 million yuan for 2024, with revenue of 2.589 billion yuan [45] - Huajin Technology reported a net profit of 29.26 billion yuan for 2024, a year-on-year increase of 8.1%, with a proposed cash dividend of 9 yuan per 10 shares [46] Group 13 - Yingke Medical reported a net profit of 1.465 billion yuan for 2024, a year-on-year increase of 282.63%, with a proposed cash dividend of 1.00 yuan per 10 shares [46] - Solar Energy reported a net profit of 1.225 billion yuan for 2024, a year-on-year decrease of 22.38%, with a proposed cash dividend of 0.56 yuan per 10 shares [46] - Dongfang Electric reported a net profit of 318 million yuan for 2024, a year-on-year decrease of 50.62%, with a proposed cash dividend of 0.32 yuan per 10 shares [47] Group 14 - Tianneng Heavy Industry reported a net loss of 262 million yuan for 2024, with revenue of 3.273 billion yuan [48] - Gangyan High-tech reported a net profit of 249 million yuan for 2024, a year-on-year decrease of 22.08%, with a proposed cash dividend of 1.00 yuan per 10 shares [48] - Shihua Machinery reported a net profit of 96.88 million yuan for 2024, a year-on-year increase of 5.35%, with revenue of 8.037 billion yuan [49] Group 15 - Gongtong Pharmaceutical reported a net loss of 27.59 million yuan for 2024, with revenue of 537 million yuan [51] - Zhongjing Electronics reported a net loss of 87.43 million yuan for 2024, with revenue of 2.932 billion yuan [53] - Yudai Development reported a net loss of 114 million yuan for 2024, with revenue of 388 million yuan [55] Group 16 - Zhenhua Technology reported a net profit of 970 million yuan for 2024, a year-on-year decrease of 63.83%, with a proposed cash dividend of 1.8 yuan per 10 shares [56] - Jierong Technology reported a net loss of 298 million yuan for 2024, with revenue of 1.357 billion yuan [58] - Changgao Electric New reported a net profit of 252 million yuan for 2024, a year-on-year increase of 45.66%, with a proposed cash dividend of 0.8 yuan per 10 shares [60] Group 17 - Shibao Detection announced a plan to acquire 81% of Zhonghuan Lianshu for 52.65 million yuan [61] - Jiangsu Boyun announced a plan to reduce its shareholding by up to 3% [62] - Jingfeng Mingyuan announced a plan to acquire 100% of Yichong Technology for 3.283 billion yuan [63]
捷荣技术2024年年报解读:净利润暴跌150.11%,经营现金流净额下滑463.84%
Xin Lang Cai Jing· 2025-04-24 01:27
Core Insights - The company reported a significant decline in key financial metrics, including a net profit loss of 150.11% and a cash flow from operating activities decrease of 463.84% in 2024 compared to 2023 [1][3][7] Financial Performance Summary - Revenue decreased by 23.25% in 2024, totaling approximately 1.36 billion yuan, down from 1.77 billion yuan in 2023. The decline was primarily due to a 25.98% drop in precision structural components revenue, which accounted for 84.87% of total revenue [2] - The net profit attributable to shareholders was -298.21 million yuan, worsening from -119.23 million yuan in 2023, indicating a significant increase in losses [3] - Basic earnings per share fell to -1.21 yuan, a decrease of 152.08% from -0.48 yuan in 2023, reflecting the company's weakened profitability [4] Expense Management Challenges - Total sales, management, research and development, and financial expenses increased by 6.04% to 322.27 million yuan, which has negatively impacted profit margins [5] - Financial expenses rose by 24.87% due to increased interest payments, indicating challenges in cost control [5] Research and Development Focus - The company invested approximately 58.99 million yuan in R&D, representing 4.35% of total revenue, an increase from 3.51% in 2023, demonstrating a commitment to innovation despite financial difficulties [6] - The number of R&D personnel decreased by 12.50% to 182, which may affect future innovation capabilities [6] Cash Flow Situation - The net cash flow from operating activities was -100.28 million yuan, a decline of 463.84% from -17.78 million yuan in 2023, indicating significant cash outflow pressures [7] - Cash flow from investing activities was -23.14 million yuan, while financing activities generated a net cash flow of 29.92 million yuan, reflecting a challenging cash flow environment [7]
捷荣技术(002855) - 关于公司及子公司2025年度拟申请综合授信及贷款并提供担保的公告
2025-04-23 15:11
证券代码:002855 证券简称:捷荣技术 公告编号:2025-017 关于公司及子公司 2025 年度拟申请综合授信及贷款 并提供担保的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 东莞捷荣技术股份有限公司(以下简称"公司")于 2025 年 4 月 23 日召开 第四届董事会第十四次会议,会议以 9 票同意、0 票反对、0 票弃权审议通过了 《关于公司及子公司 2025 年度拟申请综合授信及贷款并提供担保的议案》,公 司及子公司 2025 年度拟向银行及其他金融机构申请总额度不超过人民币 25 亿 元的综合授信及贷款额度,在此额度内由公司及子公司根据实际资金需求进行授 信及贷款申请。根据《深圳证券交易所股票上市规则》和《公司章程》的有关规 定,本次事项需提交公司股东大会审议。 具体情况如下: 一、申请综合授信额度情况概述 为满足公司发展需要和日常经营资金需求,根据公司经营目标及总体发展规 划,公司及子公司 2025 年度拟向银行及其他金融机构申请总额度不超过人民币 25 亿元的综合授信及贷款额度,在此额度内由公司及子公司根据实际资金需求 进行授信及 ...